ATRA
NASDAQ HealthcareAtara Biotherapeutics, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $6.90 |
|---|---|
| Volume | 506,533 |
| Market Cap | 49.75M |
| Beta | -0.400 |
| RSI (14-Day) | 74.8 Overbought |
| 200-Day MA | $10.98 |
| 50-Day MA | $6.85 |
| 52-Week High | $19.14 |
| 52-Week Low | $3.92 |
| P/E Ratio | 2.41 |
| Forward P/E | -26.54 |
| Price / Book | -1.36 |
🎯 Investment Strategy Scores
How ATRA scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
46/100
High dividend yield + low volatility
🔪 Falling Knife
74/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
97/100
Overbought stocks (potential short candidates)
Find ATRA in your text
Paste any text on the homepage — the tool will extract ATRA and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.